The Neuroscience Program MSU - Advancing Knowledge, Transforming Lives
Home | Students | How to Apply | Events | Directory | Resources | Contact

photoDavid I. Kaufman

D.O., 1978, College of Osteopathic Medicine, Philadelphia, PA
Medical Director, Sparrow Hospital Neurosciences
Professor and Chairperson, Dept. Neurology and Ophthalmology

Research Interests

Typically we use the eye and optic nerve as a model to determine the effectiveness of treatment strategies with brain disease.Our center has had collaborations with the National Eye Institute to longitudinally follow the effects of steroid use in patients with optic neuritis and longitudinal follow-up of patients with Anterior Ischemic Optic Neuropathy.

We are also looking at the use of experimental drugs in patients with acute onset of stroke, Tamoxifen (anti-breast cancer medicine) affects on the eye, early treatment strategies in multiple sclerosis, and etc.

Please feel free to contact me if you have any questions about my research.

Selected Publications

Search all publications in the NCBI Journal Database

Optic Neuritis Study Group. Visual Function More Than 10 Years after Optic Neuritis: Experience of the Optic Neuritis Treatment Trials. American Journal of Ophthalmology, in press.


Charters, Lynda, Kaufman DI quoted in
, Typical Optic Neuritis May Signal Multiple Sclerosis. Ophthalmology Times, March 1, 2004.

Ischemic Optic Neuropathy Decompression Trial Study Group. Surgical Quality Assurance in the Ischemic Optic Neuropathy Decompression Trial (IONDT). Controlled Clinical Trials 2003; 24: 294-305.

 

 


 

 

MSU Neuroscience Program · 108 Giltner Hall East Lansing MI 48824 · (517) 353-8947

© 2008 Michigan State University Board of Trustees
MSU is an affirmative-action, equal-opportunity employer.